Forte Biosciences

Manufacturing · Texas, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

3060 Pegasus Park Dr Bldg 6, Dallas, Tex...

Phone Number

(310) 618-6994

Website

www.fortebiorx.com

Revenue

-

Stock Symbol

FBRX

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Forte Biosciences

Forte Biosciences is a clinical-stage biopharmaceutical company developing FB102, a proprietary anti-CD122 monoclonal antibody targeting autoimmune diseases. FB102 inhibits IL-2/IL-15 receptor pathways regulating NK and T cells. Following positive Phase 1b celiac disease data (June 2025), Forte advanced to Phase 2 celiac trials and Phase 1b studies in vitiligo and alopecia areata, with topline data expected in 2026. No approved products; no revenue generated to date.Explore more
Forte Biosciences's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: FBRXShow more

Forte Biosciences Org Chart

PhoneEmail
Kazuko Matsuda, Chief Medical Officer at Forte Biosciences
United States flag for contact location.
Kazuko Matsuda

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Forte Biosciences

Compare insights from companies similar to Forte Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Forte Biosciences

11-50
Public
$78M
2017
Kazuko Matsuda, Chief Medical Officer at Forte Biosciences
Kazuko MatsudaChief Medical Officer
vTv Therapeutics
$36.8M
11-50
Public
$304.5M
1998
Paul Sekhri, Chairman, President & Chief Executive Officer at vTv Therapeutics
Paul SekhriChairman, President & CEO
Satsuma Pharmaceuticals
$7.1M
11-50
Private
$80M
2016
SH
Shunji HarutaDirector & Chief Operating Officer
SELLAS Life Sciences Grou...
<$5M
11-50
Public
$20M
2012
AS
Angelos StergiouPresident & CEO
BioSpecifics Technologies
<$5M
1-10
Private
-
1990
Thomas Wegman, President at BioSpecifics Technologies
Thomas WegmanPresident
Pmv Pharmaceuticals
51-200
Public
$498M
2013
David Mack, Co-Founder, President & Chief Executive Officer at Pmv Pharmaceuticals
David MackCo-Founder, President & CEO
Illustration of an envelope

Forte Biosciences Tech Stack

A closer look at the technologies used by Forte Biosciences

Q4

By

Q4
DocuSign

By

DocuSign
reCAPTCHA

By

Google
Google Universal Analytics

By

Google
See more technologies

Top Manufacturing Companies

Top companies in Canada by revenue

Nualtis
Bio Agri Mix
Kimia Faam Pharmaceutical
Ayurcann
Draxis Pharma
View Full List

Top companies in Australia by revenue

Mylan
Inosi Therapeutics
Geistlich
Botanix
Ena Respiratory
View Full List

Top companies in New Zealand by revenue

Pharmaceutical Compounding Nz
API Consumer Brands
Nexan
Ora Pharm
Bayer
View Full List
See more top companies

Frequently Asked Questions Regarding Forte Biosciences

What is Forte Biosciences's stock symbol?
Forte Biosciences's stock symbol is FBRX What is Forte Biosciences's official website?
Forte Biosciences's official website is www.fortebiorx.com What is Forte Biosciences's SIC code?
Forte Biosciences's SIC: 28,283 What is Forte Biosciences's NAICS code?
Forte Biosciences's NAICS: 32,325 How many employees does Forte Biosciences have?
Forte Biosciences has 11-50 employees What industry does Forte Biosciences belong to?
Forte Biosciences is in the industry of: Manufacturing, Pharmaceuticals, Business Services What is Forte Biosciences competition?
Forte Biosciences top competitors include: Satsuma Pharmaceuticals, BioSpecifics Technologies, SELLAS Life Sciences Group, vTv Therapeutics What companies has Forte Biosciences acquired?
Forte Biosciences has acquired the companies: Forte Biosciences, Priority Review Voucher What technology does Forte Biosciences use?
Some of the popular technologies that Forte Biosciences uses are: Q4, DocuSign, reCAPTCHA, Google Universal Analytics How do I contact Forte Biosciences?
Forte Biosciences contact info: Phone number: (310) 618-6994 Website: www.fortebiorx.com What does Forte Biosciences do?

Forte Biosciences is a clinical-stage biopharmaceutical company developing FB102, a proprietary anti-CD122 monoclonal antibody targeting autoimmune diseases. FB102 inhibits IL-2/IL-15 receptor pathways regulating NK and T cells. Following positive Phase 1b celiac disease data (June 2025), Forte advanced to Phase 2 celiac trials and Phase 1b studies... in vitiligo and alopecia areata, with topline data expected in 2026. No approved products; no revenue generated to date.Read More

 What are Forte Biosciences social media links?
Forte Biosciences Linkedin page Who invested in Forte Biosciences?
Forte Biosciences has 5 investors including Janus Henderson Investors, Tybourne Capital Management, OrbiMed and Alger. Is Forte Biosciences a public company?
Yes, Forte Biosciences is a public company and is traded under the symbol FBRX
See more information about Forte Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search